179 related articles for article (PubMed ID: 35741022)
1. Depleting Ly6G Positive Myeloid Cells Reduces Pancreatic Cancer-Induced Skeletal Muscle Atrophy.
Deyhle MR; Callaway CS; Neyroud D; D'Lugos AC; Judge SM; Judge AR
Cells; 2022 Jun; 11(12):. PubMed ID: 35741022
[TBL] [Abstract][Full Text] [Related]
2. Activin A-Expressing Polymorphonuclear Myeloid-Derived Suppressor Cells Infiltrate Skeletal and Cardiac Muscle and Promote Cancer Cachexia.
Dzierlega K; Chakraborty M; Lee M; Soliman AM; Parker D; Khan S; Chan YT; Akbari M; Yokota T; Winer S; Baker K; Tsai S; Winer DA; Clemente-Casares X
J Immunol; 2023 Aug; 211(3):497-507. PubMed ID: 37294291
[TBL] [Abstract][Full Text] [Related]
3. Distinct Role of CD11b
Wu SY; Chiang CS
Cells; 2019 Dec; 9(1):. PubMed ID: 31878276
[TBL] [Abstract][Full Text] [Related]
4. The complex heterogeneity of immune cell signatures across wasting tissues with C26 and 5-fluorouracil-induced cachexia.
VanderVeen BN; Cardaci TD; Bullard BM; Huss AR; McDonald SJ; Muhammed AD; Kubinak JL; Fan D; Murphy EA
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C606-C621. PubMed ID: 38189130
[TBL] [Abstract][Full Text] [Related]
5. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
6. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
[TBL] [Abstract][Full Text] [Related]
7. CD205
Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor-infiltrating Ly6G
Chang CJ; Yang YH; Chiu CJ; Lu LC; Liao CC; Liang CW; Hsu CH; Cheng AL
Int J Cancer; 2018 May; 142(9):1878-1889. PubMed ID: 29266245
[TBL] [Abstract][Full Text] [Related]
9. Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells.
Li Z; Zhao Y; Chen Z; Katz J; Michalek SM; Li Y; Zhang P
Mol Immunol; 2021 Sep; 137():187-200. PubMed ID: 34274794
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Ly6G
Heim CE; West SC; Ali H; Kielian T
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249747
[TBL] [Abstract][Full Text] [Related]
11. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
12. Elucidating granulocytic myeloid-derived suppressor cell heterogeneity during Staphylococcus aureus biofilm infection.
Bertrand BP; Heim CE; Koepsell SA; Kielian T
J Leukoc Biol; 2024 Mar; 115(4):620-632. PubMed ID: 38095415
[TBL] [Abstract][Full Text] [Related]
13. Role of Polymorphonuclear Myeloid-Derived Suppressor Cells and Neutrophils in Ischemic Stroke.
Yan H; Kawano T; Kanki H; Nishiyama K; Shimamura M; Mochizuki H; Sasaki T
J Am Heart Assoc; 2023 Mar; 12(6):e028125. PubMed ID: 36892072
[TBL] [Abstract][Full Text] [Related]
14. Granulocytic myeloid-derived suppressor cells to prevent and treat murine immune-mediated bone marrow failure.
Feng X; Kim J; Gonzalez-Matias G; Aggarwal N; Manley AL; Wu Z; Solorzano S; Batchu S; Gao S; Chen J; Young NS
Blood Adv; 2023 Jan; 7(1):73-86. PubMed ID: 35895513
[TBL] [Abstract][Full Text] [Related]
15. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
Metzger P; Kirchleitner SV; Boehmer DFR; Hörth C; Eisele A; Ormanns S; Gunzer M; Lech M; Lauber K; Endres S; Duewell P; Schnurr M; König LM
Cancer Immunol Immunother; 2020 Oct; 69(10):2101-2112. PubMed ID: 32448983
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.
Markov SD; Gonzalez D; Mehla K
Curr Protoc Pharmacol; 2020 Dec; 91(1):e80. PubMed ID: 33264501
[TBL] [Abstract][Full Text] [Related]
17. Characterization of lysosomal acid lipase in Ly6G
Zhao T; Du H; Yan C
Methods Cell Biol; 2024; 184():119-131. PubMed ID: 38555152
[TBL] [Abstract][Full Text] [Related]
18. Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets.
Capietto AH; Lee S; Clever D; Eul E; Ellis H; Ma CX; Faccio R
Cancer Immunol Res; 2021 Dec; 9(12):1400-1412. PubMed ID: 34551967
[TBL] [Abstract][Full Text] [Related]
19. Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting.
Alves CRR; MacDonald TL; Nigro P; Pathak P; Hirshman MF; Goodyear LJ; Lessard SJ
Biomed Pharmacother; 2019 Sep; 117():109197. PubMed ID: 31387190
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
